Segui
Panos Macheras
Panos Macheras
Email verificata su pharm.uoa.gr
Titolo
Citata da
Citata da
Anno
A century of dissolution research: from Noyes and Whitney to the biopharmaceutics classification system
A Dokoumetzidis, P Macheras
International journal of pharmaceutics 321 (1-2), 1-11, 2006
7582006
On the use of the Weibull function for the discernment of drug release mechanisms
V Papadopoulou, K Kosmidis, M Vlachou, P Macheras
International journal of pharmaceutics 309 (1-2), 44-50, 2006
6022006
Modeling in biopharmaceutics, pharmacokinetics and pharmacodynamics: homogeneous and heterogeneous approaches
P Macheras, A Iliadis
Springer, 2016
2262016
Quantitative biopharmaceutics classification system: the central role of dose/solubility ratio
E Rinaki, G Valsami, P Macheras
Pharmaceutical research 20 (12), 1917-1925, 2003
2222003
A reappraisal of drug release laws using Monte Carlo simulations: the prevalence of the Weibull function
K Kosmidis, P Argyrakis, P Macheras
Pharmaceutical research 20 (7), 988-995, 2003
2082003
In silico prediction of ADME and pharmacokinetics: Report of an expert meeting organised by COST B15
A Boobis, U Gundert-Remy, P Kremers, P Macheras, O Pelkonen
European Journal of Pharmaceutical Sciences 17 (4-5), 183-193, 2002
1772002
Fractal kinetics in drug release from finite fractal matrices
K Kosmidis, P Argyrakis, P Macheras
The Journal of chemical physics 119 (12), 6373-6377, 2003
1512003
Fractional kinetics in drug absorption and disposition processes
A Dokoumetzidis, P Macheras
Journal of pharmacokinetics and pharmacodynamics 36 (2), 165-178, 2009
1242009
Analysis of dissolution data using modified versions of Noyes–Whitney equation and the Weibull function
A Dokoumetzidis, V Papadopoulou, P Macheras
Pharmaceutical research 23 (2), 256-261, 2006
1222006
On the heterogeneity of drug dissolution and release
P Macheras, A Dokoumetzidis
Pharmaceutical research 17 (2), 108-112, 2000
1072000
The power law can describe the ‘entire’drug release curve from HPMC-based matrix tablets: a hypothesis
E Rinaki, G Valsami, P Macheras
International journal of pharmaceutics 255 (1-2), 199-207, 2003
1062003
Fractional kinetics in multi-compartmental systems
A Dokoumetzidis, R Magin, P Macheras
Journal of pharmacokinetics and pharmacodynamics 37 (5), 507-524, 2010
1022010
A report from the pediatric formulations task force: perspectives on the state of child-friendly oral dosage forms
A Zajicek, MJ Fossler, JS Barrett, JH Worthington, R Ternik, G Charkoftaki, ...
The AAPS journal 15 (4), 1072-1081, 2013
1002013
Identification of biowaivers among class II drugs: theoretical justification and practical examples
E Rinaki, A Dokoumetzidis, G Valsami, P Macheras
Pharmaceutical research 21 (9), 1567-1572, 2004
952004
Analysis of Case II drug transport with radial and axial release from cylinders
K Kosmidis, E Rinaki, P Argyrakis, P Macheras
International journal of pharmaceutics 254 (2), 183-188, 2003
902003
The mean dissolution time depends on the dose/solubility ratio
E Rinaki, A Dokoumetzidis, P Macheras
Pharmaceutical research 20 (3), 406-408, 2003
902003
Gastrointestinal drug absorption: is it time to consider heterogeneity as well as homogeneity?
P Macheras, P Argyrakis
Pharmaceutical research 14 (7), 842-847, 1997
891997
Biopharmaceutics of orally administered drugs
P Macheras
CRC Press, 1995
861995
A commentary on fractionalization of multi-compartmental models
A Dokoumetzidis, R Magin, P Macheras
Journal of pharmacokinetics and pharmacodynamics 37 (2), 203-207, 2010
712010
Bioavailability and bioequivalence: focus on physiological factors and variability
V Karalis, P Macheras, A Van Peer, VP Shah
Pharmaceutical research 25 (8), 1956-1962, 2008
682008
Il sistema al momento non pu eseguire l'operazione. Riprova pi tardi.
Articoli 1–20